Amicus Therapeutics (FOLD) SEC Filings & 10K Form

$10.28
+0.11 (+1.08%)
(As of 04/26/2024 ET)

Recent Amicus Therapeutics SEC Filings

DateFilerForm TypeView
04/24/2024
3:31 PM
Amicus Therapeutics (Filer)
Form DEF 14A
04/24/2024
3:32 PM
Amicus Therapeutics (Filer)
Form DEFA14A
04/16/2024
4:42 PM
Amicus Therapeutics (Issuer)
Prout Samantha (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/15/2024
3:27 PM
Amicus Therapeutics (Subject)
Crowley John F (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/03/2024
5:14 PM
Amicus Therapeutics (Issuer)
Campbell Bradley L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/19/2024
4:52 PM
Amicus Therapeutics (Issuer)
Campbell Bradley L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/15/2024
6:12 PM
Amicus Therapeutics (Issuer)
Castelli Jeff (Reporting)
Form 4/A
03/15/2024
6:13 PM
Amicus Therapeutics (Issuer)
Clark David Michael (Reporting)
Form 4/A
03/15/2024
6:14 PM
Amicus Therapeutics (Issuer)
Crowley John F (Reporting)
Form 4/A
03/15/2024
6:15 PM
Amicus Therapeutics (Issuer)
Campbell Bradley L (Reporting)
Form 4/A
03/15/2024
6:10 PM
Amicus Therapeutics (Issuer)
Rosenberg Ellen (Reporting)
Form 4/A
03/11/2024
4:36 PM
Amicus Therapeutics (Issuer)
SBLENDORIO GLENN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/06/2024
4:21 PM
Amicus Therapeutics (Issuer)
MCGLYNN MARGARET G (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/06/2024
4:22 PM
Amicus Therapeutics (Issuer)
RAAB MICHAEL (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2024
4:35 PM
Amicus Therapeutics (Subject)
MCGLYNN MARGARET G (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/01/2024
3:39 PM
Amicus Therapeutics (Subject)
Campbell Bradley L (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/01/2024
3:33 PM
Amicus Therapeutics (Subject)
Crowley John F (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/28/2024
6:02 AM
Amicus Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/20/2024
4:21 PM
Amicus Therapeutics (Issuer)
Campbell Bradley L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/20/2024
4:23 PM
Amicus Therapeutics (Issuer)
Crowley John F (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/15/2024
3:19 PM
Amicus Therapeutics (Subject)
Clark David Michael (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/15/2024
3:19 PM
Amicus Therapeutics (Subject)
Campbell Bradley L (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/14/2024
8:22 AM
Amicus Therapeutics (Subject)
Avoro Capital Advisors LLC (Filed by)
Form SC 13G/A
02/08/2024
3:40 PM
Amicus Therapeutics (Issuer)
Rosenberg Ellen (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/05/2024
6:22 PM
Amicus Therapeutics (Issuer)
Crowley John F (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/05/2024
6:22 PM
Amicus Therapeutics (Issuer)
Campbell Bradley L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/01/2024
3:44 PM
Amicus Therapeutics (Subject)
Crowley John F (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/01/2024
3:45 PM
Amicus Therapeutics (Subject)
Campbell Bradley L (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/24/2024
4:20 PM
Amicus Therapeutics (Issuer)
Crowley John F (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/22/2024
3:18 PM
Amicus Therapeutics (Subject)
Crowley John F (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/18/2024
4:09 PM
Amicus Therapeutics (Issuer)
Crowley John F (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/16/2024
3:25 PM
Amicus Therapeutics (Subject)
Crowley John F (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/11/2024
5:33 PM
Amicus Therapeutics (Issuer)
Crowley John F (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/11/2024
5:34 PM
Amicus Therapeutics (Issuer)
Campbell Bradley L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/11/2024
5:34 PM
Amicus Therapeutics (Issuer)
Castelli Jeff (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/11/2024
5:35 PM
Amicus Therapeutics (Issuer)
Clark David Michael (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/11/2024
5:35 PM
Amicus Therapeutics (Issuer)
Rosenberg Ellen (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/10/2024
3:06 PM
Amicus Therapeutics (Subject)
Crowley John F (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/09/2024
5:07 PM
Amicus Therapeutics (Issuer)
Prout Samantha (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/09/2024
5:08 PM
Amicus Therapeutics (Issuer)
Clark David Michael (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/09/2024
3:27 PM
Amicus Therapeutics (Subject)
Clark David Michael (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
The Hard Truth About Investing For Retirement (Ad)

Here’s the cold, hard truth about investing: The more capital you have, the more risk averse you can afford to be. But when you’re staring down the barrel of retirement and you’ve only got 5, 10, 50 or $100,000 saved, you’ve got to be more aggressive. In an exclusive online training, the Market expert Steven Place is revealing a powerful “roadmap” that’s leading everyday investors to easy, triple-digit wins, even if they don’t have a lot of experience in trading.

Click To Access This Powerful Training Right Now!
01/09/2024
3:27 PM
Amicus Therapeutics (Subject)
Prout Samantha (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/08/2024
8:09 AM
Amicus Therapeutics (Subject)
JPMORGAN CHASE & CO (Filed by)
JPMORGAN CHASE & CO (Filed by)
Form SC 13G
01/08/2024
6:01 AM
Amicus Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/05/2024
5:01 PM
Amicus Therapeutics (Issuer)
Prout Samantha (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/05/2024
5:01 PM
Amicus Therapeutics (Issuer)
Clark David Michael (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/05/2024
5:02 PM
Amicus Therapeutics (Issuer)
Crowley John F (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/05/2024
5:03 PM
Amicus Therapeutics (Issuer)
Campbell Bradley L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/05/2024
5:03 PM
Amicus Therapeutics (Issuer)
Rosenberg Ellen (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/05/2024
5:04 PM
Amicus Therapeutics (Issuer)
Castelli Jeff (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/04/2024
5:24 PM
Amicus Therapeutics (Issuer)
Rosenberg Ellen (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/04/2024
5:26 PM
Amicus Therapeutics (Issuer)
Clark David Michael (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/04/2024
5:33 PM
Amicus Therapeutics (Issuer)
Crowley John F (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/04/2024
5:35 PM
Amicus Therapeutics (Issuer)
Campbell Bradley L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/04/2024
5:36 PM
Amicus Therapeutics (Issuer)
Castelli Jeff (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/04/2024
5:17 PM
Amicus Therapeutics (Issuer)
Harford Simon N.R. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/03/2024
5:30 PM
Amicus Therapeutics (Issuer)
Prout Samantha (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/02/2024
3:32 PM
Amicus Therapeutics (Subject)
Campbell Bradley L (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/02/2024
3:32 PM
Amicus Therapeutics (Subject)
Rosenberg Ellen (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/29/2023
4:18 PM
Amicus Therapeutics (Issuer)
Amicus Therapeutics (Issuer)
Castelli Jeff (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/28/2023
4:08 PM
Amicus Therapeutics (Issuer)
Rosenberg Ellen (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/28/2023
4:09 PM
Amicus Therapeutics (Issuer)
Prout Samantha (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/28/2023
3:21 PM
Amicus Therapeutics (Subject)
Castelli Jeff (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/26/2023
3:25 PM
Amicus Therapeutics (Subject)
Rosenberg Ellen (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/26/2023
3:25 PM
Amicus Therapeutics (Subject)
Prout Samantha (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/20/2023
3:41 PM
Amicus Therapeutics (Issuer)
Castelli Jeff (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/20/2023
3:20 PM
Amicus Therapeutics (Subject)
Castelli Jeff (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/19/2023
4:54 PM
Amicus Therapeutics (Issuer)
Clark David Michael (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/19/2023
4:55 PM
Amicus Therapeutics (Issuer)
Crowley John F (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/19/2023
4:56 PM
Amicus Therapeutics (Issuer)
Rosenberg Ellen (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/19/2023
4:58 PM
Amicus Therapeutics (Issuer)
Campbell Bradley L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/15/2023
3:37 PM
Amicus Therapeutics (Subject)
Crowley John F (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/08/2023
3:31 PM
Amicus Therapeutics (Subject)
MORGAN STANLEY (Filed by)
Form SC 13G/A
12/05/2023
4:03 PM
Amicus Therapeutics (Issuer)
Crowley John F (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/05/2023
4:07 PM
Amicus Therapeutics (Issuer)
Campbell Bradley L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/05/2023
5:03 AM
Amicus Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/17/2023
4:23 PM
Amicus Therapeutics (Issuer)
Crowley John F (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/08/2023
4:25 PM
Amicus Therapeutics (Filer)
Form S-3ASR
11/08/2023
6:00 AM
Amicus Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/03/2023
6:37 PM
Amicus Therapeutics (Issuer)
Crowley John F (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/03/2023
6:38 PM
Amicus Therapeutics (Issuer)
Campbell Bradley L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/18/2023
6:57 PM
Amicus Therapeutics (Issuer)
Crowley John F (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/16/2023
3:23 PM
Amicus Therapeutics (Subject)
Crowley John F (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/05/2023
4:00 PM
Amicus Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/04/2023
5:58 PM
Amicus Therapeutics (Issuer)
Crowley John F (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/04/2023
5:57 PM
Amicus Therapeutics (Issuer)
Campbell Bradley L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/02/2023
3:11 PM
Amicus Therapeutics (Subject)
Campbell Bradley L (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/02/2023
3:13 PM
Amicus Therapeutics (Subject)
Crowley John F (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/02/2023
7:48 AM
Amicus Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/28/2023
11:00 AM
Amicus Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/27/2023
6:00 AM
Amicus Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
A new way to collect income from stocks (Ad)

Most people think of BUYING options when they talk about options. It’s how speculators leverage large sums of money hoping that a stock moves in the “right” direction over a certain period of time. The problem is - they don’t always pay off when you buy them. In fact, a contributing writer at the Financial Post studied options extensively…

Click here to see me place one of these trades LIVE on camera.
09/18/2023
4:09 PM
Amicus Therapeutics (Issuer)
Crowley John F (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/12/2023
3:10 PM
Amicus Therapeutics (Subject)
Quimi Daphne (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/11/2023
3:13 PM
Amicus Therapeutics (Subject)
Quimi Daphne (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/06/2023
4:29 PM
Amicus Therapeutics (Issuer)
Campbell Bradley L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/06/2023
4:31 PM
Amicus Therapeutics (Issuer)
Crowley John F (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/01/2023
3:11 PM
Amicus Therapeutics (Subject)
Crowley John F (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/01/2023
3:19 PM
Amicus Therapeutics (Subject)
Campbell Bradley L (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/23/2023
4:46 PM
Amicus Therapeutics (Issuer)
Harford Simon N.R. (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
08/23/2023
4:59 PM
Amicus Therapeutics (Issuer)
Harford Simon N.R. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NASDAQ:FOLD) was last updated on 4/28/2024 by MarketBeat.com Staff

From Our Partners